After reviewing the data submitted over the safety offered by the vaccines developed by two Indian pharma firms the Drugs Controller General of India (DCGI) approved two vaccines for emergency use.
The DCGI gave its nod for the vaccines developed by Serum Institute of India and Bharat Biotech for emergency use of vaccines in India with some restrictions.
On this occasion, Prime Minister Narendra Modi congratulated the Indian pharma companies for getting approval for the vaccines from the DCGI.In a series of tweets, Narendra Modi congratulated the hard work of scientists and innovators and called the vaccine approval as a decisive turning point. He also thanked the frontline workers, sanitation workers, and all Corona warriors
“A decisive turning point to strengthen a spirited fight! DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators,” Modi’s tweet reads.
“It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion.” he tweeted.
As the DCGI approved the vaccines developed by two pharma companies, the vaccine is expected to roll out very soon. In the first phase, the centre is aiming to vaccinate 3 crore Indians.Out of the three crore beneficiaries, one crore healthcare workers will be vaccinated, while the other 2 crore beneficiaries will be frontline workers. The vaccine drive is expected to start soon.
It has to be noted that recently, the union government directed the States and Union Territories to conduct a mock drill for the Coronavirus vaccine drive,
Recent Random Post:
